{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:22:32Z","timestamp":1793067752982,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer (BC) is one of the most common types of cancer among women, leading to death. More than 90% of deaths from BC are due to hematogenous metastases. In the cellular and tissue levels, the aggressiveness of BC is linked with epithelial\u2013mesenchymal transition, leading to enhanced cell motility and spread in the bloodstream, leading to tumor expansion. This review focuses on the vascular mechanisms that facilitate metastatic dissemination in BC, highlighting the influence of blood vessels, hemodynamic forces, and vascular microenvironmental properties on tumor cell spread. Particular emphasis is placed on the role of endothelial dysfunction within common comorbid conditions and how these alterations may increase metastatic propensity. In addition, we discussed whether improving endothelial health and effectively managing comorbidities could help reduce metastatic progression.<\/jats:p>","DOI":"10.1007\/s12672-026-04437-y","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:06:24Z","timestamp":1768637184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3916-3075","authenticated-orcid":false,"given":"Matluba","family":"Mirzaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3119-8539","authenticated-orcid":false,"given":"Akbarjon","family":"Mirzayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6353-1964","authenticated-orcid":false,"given":"Bakhtiyar","family":"Iriskulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4449-0622","authenticated-orcid":false,"given":"Sevara B.","family":"Azimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2645-9553","authenticated-orcid":false,"given":"Shamsiddin","family":"Nizamkhodjaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-1061","authenticated-orcid":false,"given":"Akmal M.","family":"Asrorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"1","key":"4437_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43556-025-00261-y","volume":"6","author":"X Dai","year":"2025","unstructured":"Dai X, Xi M, Li J. Cancer metastasis: molecular mechanisms and therapeutic interventions. Mol Biomed. 2025;6(1):20.","journal-title":"Mol Biomed"},{"issue":"12","key":"4437_CR2","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.3390\/ijms23126806","volume":"23","author":"M Park","year":"2022","unstructured":"Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci. 2022;23(12):6806.","journal-title":"Int J Mol Sci"},{"key":"4437_CR3","doi-asserted-by":"publisher","first-page":"1442888","DOI":"10.3389\/fphar.2024.1442888","volume":"15","author":"C Biray Avci","year":"2024","unstructured":"Biray Avci C, Goker Bagca B, Nikanfar M, Takanlou LS, Takanlou MS, Nourazarian A. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Front Pharmacol. 2024;15:1442888.","journal-title":"Front Pharmacol"},{"key":"4437_CR4","first-page":"9423907","volume":"2019","author":"C Scheau","year":"2019","unstructured":"Scheau C, Badarau IA, Costache R, Caruntu C, Mihai GL, Didilescu AC et al. The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma. Anal Cell Pathol (Amsterdam). 2019;2019:9423907.","journal-title":"Anal Cell Pathol (Amsterdam)"},{"issue":"1","key":"4437_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","volume":"26","author":"M Akhtar","year":"2019","unstructured":"Akhtar M, Haider A, Rashid S, Al-Nabet A. Paget\u2019s seed and soil theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol. 2019;26(1):69\u201374.","journal-title":"Adv Anat Pathol"},{"key":"4437_CR6","doi-asserted-by":"publisher","first-page":"9077926","DOI":"10.1155\/2024\/9077926","volume":"2024","author":"A Pathak","year":"2024","unstructured":"Pathak A, Pal AK, Roy S, Nandave M, Jain K. Role of angiogenesis and its biomarkers in development of targeted tumor therapies. Stem Cells Int. 2024;2024:9077926.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4437_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Therapy. 2023;8(1):70.","journal-title":"Signal Transduct Target Therapy"},{"key":"4437_CR8","doi-asserted-by":"publisher","first-page":"175586","DOI":"10.1016\/j.ejphar.2023.175586","volume":"949","author":"S Ghalehbandi","year":"2023","unstructured":"Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586.","journal-title":"Eur J Pharmacol"},{"key":"4437_CR9","doi-asserted-by":"publisher","first-page":"120667","DOI":"10.1016\/j.saa.2021.120667","volume":"268","author":"M Kopec","year":"2022","unstructured":"Kopec M, Abramczyk H. The role of pro- and antiangiogenic factors in angiogenesis process by Raman spectroscopy. Spectrochimica Acta Part Mol Biomol Spectrosc. 2022;268:120667.","journal-title":"Spectrochimica Acta Part Mol Biomol Spectrosc"},{"issue":"7","key":"4437_CR10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/biology12071028","volume":"12","author":"M Penco-Campillo","year":"2023","unstructured":"Penco-Campillo M, Pages G, Martial S. Angiogenesis and lymphangiogenesis in medulloblastoma development. Biology. 2023;12(7):1028.","journal-title":"Biology"},{"issue":"1","key":"4437_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/genes13010152","volume":"13","author":"P Mabeta","year":"2022","unstructured":"Mabeta P, Hull R, Dlamini Z. LncRNAs and the angiogenic switch in cancer: clinical significance and therapeutic opportunities. Genes. 2022;13(1):152.","journal-title":"Genes"},{"issue":"9","key":"4437_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci: CMLS. 2020;77(9):1745\u201370.","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"1","key":"4437_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/jcm9010084","volume":"9","author":"RI Teleanu","year":"2020","unstructured":"Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor angiogenesis and Anti-Angiogenic strategies for cancer treatment. J Clin Med. 2020;9(1):84.","journal-title":"J Clin Med"},{"issue":"66","key":"4437_CR14","doi-asserted-by":"publisher","first-page":"32556","DOI":"10.18632\/oncotarget.25863","volume":"9","author":"H Jayatilaka","year":"2018","unstructured":"Jayatilaka H, Umanzor FG, Shah V, Meirson T, Russo G, Starich B, et al. Tumor cell density regulates matrix metalloproteinases for enhanced migration. Oncotarget. 2018;9(66):32556\u201369.","journal-title":"Oncotarget"},{"issue":"22","key":"4437_CR15","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1158\/0008-5472.CAN-16-3279","volume":"77","author":"AD Wong","year":"2017","unstructured":"Wong AD, Searson PC. Mitosis-mediated intravasation in a tissue-engineered tumor-microvessel platform. Cancer Res. 2017;77(22):6453\u201361.","journal-title":"Cancer Res"},{"key":"4437_CR16","first-page":"83","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckland NZ). 2015;3:83\u201392.","journal-title":"Hypoxia (Auckland NZ)"},{"issue":"1","key":"4437_CR17","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00238.2015","volume":"311","author":"SP Chiang","year":"2016","unstructured":"Chiang SP, Cabrera RM, Segall JE. Tumor cell intravasation. Am J Physiol Cell Physiol. 2016;311(1):C1\u201314.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"4437_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ceb.2012.08.005","volume":"24","author":"RL Klemke","year":"2012","unstructured":"Klemke RL. Trespassing cancer cells: \u2018fingerprinting\u2019 invasive protrusions reveals metastatic culprits. Curr Opin Cell Biol. 2012;24(5):662\u20139.","journal-title":"Curr Opin Cell Biol"},{"issue":"Pt 3","key":"4437_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.semcancer.2022.03.011","volume":"86","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cao Y. The impact of VEGF on cancer metastasis and systemic disease. Sem Cancer Biol. 2022;86(Pt 3):251\u201361.","journal-title":"Sem Cancer Biol"},{"issue":"2\u20133","key":"4437_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.mvr.2007.05.006","volume":"74","author":"AM Goodwin","year":"2007","unstructured":"Goodwin AM. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res. 2007;74(2\u20133):172\u201383.","journal-title":"Microvasc Res"},{"key":"4437_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cancers13235917","volume":"13","author":"MR D\u2019Andrea","year":"2021","unstructured":"D\u2019Andrea MR, Cereda V, Coppola L, Giordano G, Remo A, De Santis E. Propensity for early metastatic spread in breast cancer: role of tumor vascularization features and tumor immune infiltrate. Cancers. 2021;13:23.","journal-title":"Cancers"},{"key":"4437_CR22","doi-asserted-by":"publisher","first-page":"153922","DOI":"10.1016\/j.prp.2022.153922","volume":"234","author":"H Chavoshi","year":"2022","unstructured":"Chavoshi H, Poormolaie N, Vahedian V, Kazemzadeh H, Mir A, Nejabati HR, et al. Vascular mimicry: a potential therapeutic target in breast cancer. Pathol Res Pract. 2022;234:153922.","journal-title":"Pathol Res Pract"},{"key":"4437_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2020.00220","volume":"10","author":"MA Andonegui-Elguera","year":"2020","unstructured":"Andonegui-Elguera MA, Alfaro-Mora Y, C\u00e1ceres-Guti\u00e9rrez R, Caro-S\u00e1nchez CHS, Herrera LA, D\u00edaz-Ch\u00e1vez J.An overview of vasculogenic mimicry in breast cancer. Front Oncol. 2020;10:220.","journal-title":"Front Oncol"},{"key":"4437_CR24","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.adcanc.2025.100153","volume":"15","author":"C Guan","year":"2025","unstructured":"Guan C, Hao L, Gong B, Zheng L. The mechanisms of action and targeting potential of vasculogenic mimicry in breast cancer metastasis. Adv Cancer Biol Metastasis. 2025;15:100153.","journal-title":"Adv Cancer Biol Metastasis"},{"issue":"8","key":"4437_CR25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.32604\/biocell.2023.028343","volume":"47","author":"X Li","year":"2023","unstructured":"Li X, Zheng J, Zhu J, Huang X, Zhu H, Chen B. Circulating tumor cells: biological features and survival mechanisms. Biocell. 2023;47(8):1771\u201381.","journal-title":"Biocell"},{"issue":"3","key":"4437_CR26","doi-asserted-by":"publisher","first-page":"103969","DOI":"10.1016\/j.isci.2022.103969","volume":"25","author":"M Peralta","year":"2022","unstructured":"Peralta M, Osmani N, Goetz JG. Circulating tumor cells: towards mechanical phenotyping of metastasis. iScience. 2022;25(3):103969.","journal-title":"iScience"},{"issue":"9","key":"4437_CR27","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/biomedicines12092137","volume":"12","author":"MC Rapanotti","year":"2024","unstructured":"Rapanotti MC, Cenci T, Scioli MG, Cugini E, Anzillotti S, Savino L et al. Circulating tumor cells: origin, role, current applications, and future perspectives for personalized medicine. Biomedicines. 2024;12(9):2137.","journal-title":"Biomedicines"},{"key":"4437_CR28","doi-asserted-by":"publisher","first-page":"1188499","DOI":"10.3389\/fcell.2023.1188499","volume":"11","author":"K Kurma","year":"2023","unstructured":"Kurma K, Alix-Panabi\u00e8res C. Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype. Front Cell Dev Biology. 2023;11:1188499.","journal-title":"Front Cell Dev Biology"},{"issue":"3","key":"4437_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","volume":"32","author":"B Strilic","year":"2017","unstructured":"Strilic B, Offermanns S. Intravascular survival and extravasation of tumor cells. Cancer Cell. 2017;32(3):282\u201393.","journal-title":"Cancer Cell"},{"issue":"2","key":"4437_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41568-019-0221-x","volume":"20","author":"G Follain","year":"2020","unstructured":"Follain G, Herrmann D, Harlepp S, Hyenne V, Osmani N, Warren SC, et al. Fluids and their mechanics in tumour transit: shaping metastasis. Nat Rev Cancer. 2020;20(2):107\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"Pt 13","key":"4437_CR31","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1242\/jcs.069443","volume":"123","author":"K Stoletov","year":"2010","unstructured":"Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S, et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci. 2010;123(Pt 13):2332\u201341.","journal-title":"J Cell Sci"},{"key":"4437_CR32","doi-asserted-by":"publisher","first-page":"104463","DOI":"10.1016\/j.breast.2025.104463","volume":"81","author":"L Gerratana","year":"2025","unstructured":"Gerratana L, Gianni C, Nicol\u00f2 E, Pontolillo L, Bidard FC, Reduzzi C, et al. Mapping breast cancer therapy with circulating tumor cells: the expert perspective. Breast (Edinburgh Scotland). 2025;81:104463.","journal-title":"Breast (Edinburgh Scotland)"},{"issue":"2","key":"4437_CR33","doi-asserted-by":"publisher","first-page":"pkz026","DOI":"10.1093\/jncics\/pkz026","volume":"3","author":"L Thery","year":"2019","unstructured":"Thery L, Meddis A, Cabel L, Proudhon C, Latouche A, Pierga JY, et al. Circulating tumor cells in early breast cancer. JNCI Cancer Spectr. 2019;3(2):pkz026.","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"4437_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10585-007-9096-4","volume":"25","author":"S Gout","year":"2008","unstructured":"Gout S, Tremblay PL, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis. 2008;25(4):335\u201344.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"4437_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10555-020-09942-2","volume":"40","author":"X Cheng","year":"2021","unstructured":"Cheng X, Cheng K. Visualizing cancer extravasation: from mechanistic studies to drug development. Cancer Metastasis Rev. 2021;40(1):71\u201388.","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"4437_CR36","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/cells8121602","volume":"8","author":"X Li","year":"2019","unstructured":"Li X, Li Y, Lu W, Chen M, Ye W, Zhang D. The tumor vessel targeting strategy: A Double-Edged sword in tumor metastasis. Cells. 2019;8(12):1602.","journal-title":"Cells"},{"issue":"4","key":"4437_CR37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","volume":"27","author":"L Claesson-Welsh","year":"2021","unstructured":"Claesson-Welsh L, Dejana E, McDonald DM. Permeability of the endothelial barrier: identifying and reconciling controversies. Trends Mol Med. 2021;27(4):314\u201331.","journal-title":"Trends Mol Med"},{"issue":"17","key":"4437_CR38","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.231563","volume":"132","author":"TA Allen","year":"2019","unstructured":"Allen TA, Asad D, Amu E, Hensley MT, Cores J, Vandergriff A et al. Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential. J Cell Sci. 2019;132(17):jcs231563.","journal-title":"J Cell Sci"},{"issue":"1","key":"4437_CR39","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s42003-024-06200-x","volume":"7","author":"C Galloni","year":"2024","unstructured":"Galloni C, Egnuni T, Zahed Mohajerani S, Ye J, Mittnacht S, Speirs V, et al. Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling. Commun Biology. 2024;7(1):602.","journal-title":"Commun Biology"},{"issue":"13","key":"4437_CR40","doi-asserted-by":"publisher","first-page":"e23785","DOI":"10.1096\/fj.202400380R","volume":"38","author":"CC Okorafor","year":"2024","unstructured":"Okorafor CC, Shastri S, Wen K, Ebong EE. Mechanisms of triple-negative breast cancer extravasation: impact of the physical environment and endothelial glycocalyx. FASEB J. 2024;38(13):e23785.","journal-title":"FASEB J"},{"issue":"10","key":"4437_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1158\/1541-7786.MCR-09-0551","volume":"8","author":"MD Martin","year":"2010","unstructured":"Martin MD, Kremers GJ, Short KW, Rocheleau JV, Xu L, Piston DW, et al. Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment. Mol Cancer Res. 2010;8(10):1319\u201327.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4437_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, et al. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Therapy. 2024;9(1):236.","journal-title":"Signal Transduct Target Therapy"},{"key":"4437_CR43","doi-asserted-by":"publisher","first-page":"134887","DOI":"10.1016\/j.foodchem.2022.134887","volume":"405","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Stockmann R, Ng K, Broadbent JA, Stockwell S, Suleria H, et al. Characterization of Fe(III)-binding peptides from pea protein hydrolysates targeting enhanced iron bioavailability. Food Chem. 2023;405:134887.","journal-title":"Food Chem"},{"issue":"1","key":"4437_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13577-023-00992-6","volume":"37","author":"K Gostomczyk","year":"2024","unstructured":"Gostomczyk K, Marsool MDM, Tayyab H, Pandey A, Borowczak J, Macome F, et al. Targeting circulating tumor cells to prevent metastases. Hum Cell. 2024;37(1):101\u201320.","journal-title":"Hum Cell"},{"issue":"8","key":"4437_CR45","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1111\/cas.14942","volume":"112","author":"T Tomita","year":"2021","unstructured":"Tomita T, Kato M, Hiratsuka S. Regulation of vascular permeability in cancer metastasis. Cancer Sci. 2021;112(8):2966\u201374.","journal-title":"Cancer Sci"},{"issue":"17","key":"4437_CR46","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/S0959-8049(02)00218-6","volume":"38","author":"DM O\u2019Hanlon","year":"2022","unstructured":"O\u2019Hanlon DM, Fitzsimons H, Lynch J, Tormey S, Malone C, Given HF. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer (Oxford, England: 1990). 2002;38(17):2252\u20137.","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"8","key":"4437_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","volume":"16","author":"EA Kuczynski","year":"2019","unstructured":"Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nat Reviews Clin Oncol. 2019;16(8):469\u201393.","journal-title":"Nat Reviews Clin Oncol"},{"key":"4437_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1359069","volume":"14","author":"R Zhang","year":"2024","unstructured":"Zhang R, Yao Y, Gao H, Hu X. Mechanisms of angiogenesis in tumour. 2024;14:1359069.","journal-title":"Front Oncol"},{"issue":"2","key":"4437_CR49","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/ijms25020921","volume":"25","author":"I Carrera-Aguado","year":"2024","unstructured":"Carrera-Aguado I, Marcos-Zazo L, Carrancio-Sal\u00e1n P, Guerra-Paes E, S\u00e1nchez-Juanes F, Mu\u00f1oz-F\u00e9lix JM. The Inhibition of vessel Co-Option as an emerging strategy for cancer therapy. Int J Mol Sci. 2024;25(2):921.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4437_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/path.4845","volume":"241","author":"VL Bridgeman","year":"2017","unstructured":"Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. J Pathol. 2017;241(3):362\u201374.","journal-title":"J Pathol"},{"issue":"1","key":"4437_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10456-019-09693-x","volume":"23","author":"P Garc\u00eda-G\u00f3mez","year":"2020","unstructured":"Garc\u00eda-G\u00f3mez P, Valiente M. Vascular co-option in brain metastasis. Angiogenesis. 2020;23(1):3\u20138.","journal-title":"Angiogenesis"},{"key":"4437_CR52","doi-asserted-by":"publisher","first-page":"1086251","DOI":"10.3389\/fonc.2023.1086251","volume":"13","author":"W Chen","year":"2023","unstructured":"Chen W, Zhang Y, Tang J, Wei D, Liao H, Zhang S, et al. Correlations between contrast-enhanced ultrasound and microvessel density in non-small cell lung cancer: a prospective study. Front Oncol. 2023;13:1086251.","journal-title":"Front Oncol"},{"issue":"2","key":"4437_CR53","first-page":"100","volume":"17","author":"A Abbasi","year":"2023","unstructured":"Abbasi A, Ghaffarizadeh F, Mojdeganlou H. Prognostic significance of microvessel density in invasive ductal carcinoma of breast. Int J hematology-oncology Stem Cell Res. 2023;17(2):100\u20135.","journal-title":"Int J hematology-oncology Stem Cell Res"},{"issue":"2","key":"4437_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1593\/neo.81338","volume":"11","author":"S Halin","year":"2009","unstructured":"Halin S, Rudolfsson SH, Van Rooijen N, Bergh A. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia (New York NY). 2009;11(2):177\u201386.","journal-title":"Neoplasia (New York NY)"},{"issue":"4","key":"4437_CR55","first-page":"341","volume":"36","author":"TF Hansen","year":"2013","unstructured":"Hansen TF, Nielsen BS, Jakobsen A, S\u00f8rensen FB. Visualising and quantifying angiogenesis in metastatic colorectal cancer: a comparison of methods and their predictive value for chemotherapy response. Cell Oncol (Dordrecht Netherlands). 2013;36(4):341\u201350.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"key":"4437_CR56","doi-asserted-by":"crossref","unstructured":"Kraby MR, Kr\u00fcger K, Opdahl S, Vatten LJ, Akslen LA, Bofin AM. Microvascular proliferation in luminal Aand basal-like breast cancer subtypes; 2015.","DOI":"10.1136\/jclinpath-2015-203037"},{"issue":"1","key":"4437_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.acthis.2013.06.005","volume":"116","author":"LB Maschio","year":"2014","unstructured":"Maschio LB, Madallozo BB, Capellasso BA, Jardim BV, Moschetta MG, Jampietro J, et al. Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1\u03b1 and CD34 in invasive ductal carcinoma of the breast. Acta Histochem. 2014;116(1):148\u201357.","journal-title":"Acta Histochem"},{"issue":"1","key":"4437_CR58","doi-asserted-by":"publisher","first-page":"30341","DOI":"10.1038\/s41598-024-82106-2","volume":"14","author":"Y Culha","year":"2024","unstructured":"Culha Y, Ozdemir C, Davarci SE, \u00dcnl\u00fc B, Olgun AKM, Demir H, et al. Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer. Sci Rep. 2024;14(1):30341.","journal-title":"Sci Rep"},{"key":"4437_CR59","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12885-015-1269-y","volume":"15","author":"G Zang","year":"2015","unstructured":"Zang G, Gustafsson K, Jamalpour M, Hong J, Genov\u00e9 G, Welsh M. Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts. BMC Cancer. 2015;15:234.","journal-title":"BMC Cancer"},{"issue":"15","key":"4437_CR60","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1111\/febs.16046","volume":"289","author":"MK Sznurkowska","year":"2022","unstructured":"Sznurkowska MK, Aceto N. The gate to metastasis: key players in cancer cell intravasation. FEBS J. 2022;289(15):4336\u201354.","journal-title":"FEBS J"},{"issue":"12","key":"4437_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126415","volume":"25","author":"R Wakasugi","year":"2024","unstructured":"Wakasugi R, Suzuki K, Kaneko-Kawano T. Molecular mechanisms regulating vascular endothelial permeability. Int J Mol Sci. 2024;25(12):6415.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4437_CR62","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/ijms23073645","volume":"23","author":"JL Wautier","year":"2022","unstructured":"Wautier JL, Wautier MP. Vascular permeability in diseases. Int J Mol Sci. 2022;23(7):3645.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4437_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2183\/pjab.88.53","volume":"88","author":"H Maeda","year":"2012","unstructured":"Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Japan Acad Ser B Phys Biol Sci. 2012;88(3):53\u201371.","journal-title":"Proc Japan Acad Ser B Phys Biol Sci"},{"key":"4437_CR64","first-page":"21","volume":"5","author":"JC Forster","year":"2017","unstructured":"Forster JC, Harriss-Phillips WM, Douglass MJ, Bezak E. A review of the development of tumor vasculature and its effects on the tumor microenvironment. Hypoxia (Auckland NZ). 2017;5:21\u201332.","journal-title":"Hypoxia (Auckland NZ)"},{"issue":"1","key":"4437_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.devcel.2018.02.015","volume":"45","author":"G Follain","year":"2018","unstructured":"Follain G, Osmani N, Azevedo AS, Allio G, Mercier L, Karreman MA, et al. Hemodynamic forces tune the Arrest, Adhesion, and extravasation of Circulating tumor cells. Dev Cell. 2018;45(1):33\u2013e5212.","journal-title":"Dev Cell"},{"issue":"7","key":"4437_CR66","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1073\/pnas.1818322116","volume":"116","author":"C Voutouri","year":"2019","unstructured":"Voutouri C, Kirkpatrick ND, Chung E, Mpekris F, Baish JW, Munn LL, et al. Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies. Proc Natl Acad Sci USA. 2019;116(7):2662\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4437_CR67","doi-asserted-by":"publisher","first-page":"101073","DOI":"10.1016\/j.isci.2020.101073","volume":"23","author":"F Font-Clos","year":"2020","unstructured":"Font-Clos F, Zapperi S, La Porta CAM. Blood flow contributions to cancer metastasis. iScience. 2020;23(5):101073.","journal-title":"iScience"},{"issue":"1","key":"4437_CR68","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1038\/s41598-020-63316-w","volume":"10","author":"HA Cognart","year":"2020","unstructured":"Cognart HA, Viovy JL, Villard C. Fluid shear stress coupled with narrow constrictions induce cell type-dependent morphological and molecular changes in SK-BR-3 and MDA-MB-231 cells. Sci Rep. 2020;10(1):6386.","journal-title":"Sci Rep"},{"issue":"1","key":"4437_CR69","doi-asserted-by":"publisher","first-page":"23231","DOI":"10.1038\/s41598-021-02482-x","volume":"11","author":"C Casas-Arozamena","year":"2021","unstructured":"Casas-Arozamena C, Otero-Cacho A, Carnero B, Almenglo C, Aymerich M, Alonso-Alconada L, et al. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis. Sci Rep. 2021;11(1):23231.","journal-title":"Sci Rep"},{"key":"4437_CR70","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3332\/ecancer.2023.1512","volume":"17","author":"S Subramaniam","year":"2023","unstructured":"Subramaniam S, Kong YC, Yip CH, Thiagarajan M, Pailoor J, Zaharah H, et al. Association between pre-existing cardiometabolic comorbidities and the pathological profiles of breast cancer at initial diagnosis: a cross sectional study. Ecancermedicalscience. 2023;17:1512.","journal-title":"Ecancermedicalscience"},{"issue":"15","key":"4437_CR71","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/cncr.33530","volume":"127","author":"AE Connor","year":"2021","unstructured":"Connor AE, Schmaltz CL, Jackson-Thompson J, Visvanathan K. Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer. Cancer. 2021;127(15):2614\u201322.","journal-title":"Cancer"},{"issue":"12","key":"4437_CR72","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41571-019-0249-6","volume":"16","author":"C Renzi","year":"2019","unstructured":"Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, et al. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Reviews Clin Oncol. 2019;16(12):746\u201361.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"11","key":"4437_CR73","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.31557\/APJCP.2023.24.11.3805","volume":"24","author":"T Wadasadawala","year":"2023","unstructured":"Wadasadawala T, Datta D, Puchali N, Rane P, Sen S, Mohanty S, et al. Prospective study of incidence and impact of comorbidities on breast cancer survival from India. Asian Pac J Cancer Prev. 2023;24(11):3805\u201314.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4437_CR74","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1038\/srep44877","volume":"7","author":"H Han","year":"2017","unstructured":"Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7:44877.","journal-title":"Sci Rep"},{"issue":"9","key":"4437_CR75","doi-asserted-by":"publisher","first-page":"101207","DOI":"10.1016\/j.jacadv.2024.101207","volume":"3","author":"DJ Leedy","year":"2024","unstructured":"Leedy DJ, Voit JM, Rillamas-Sun E, Kwan ML, Shen H, Li S, et al. Blood pressure and cardiovascular risk in women with breast cancer: the pathways heart study. JACC Adv. 2024;3(9):101207.","journal-title":"JACC Adv"},{"issue":"2","key":"4437_CR76","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/HYPERTENSIONAHA.111.186544","volume":"59","author":"J Gasowski","year":"2012","unstructured":"Gasowski J, Piotrowicz K. Breast cancer, age, and hypertension: a complex issue. Hypertens (Dallas Tex : 1979). 2012;59(2):186\u20138.","journal-title":"Hypertens (Dallas Tex : 1979)"},{"issue":"2","key":"4437_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/HYPERTENSIONAHA.111.171736","volume":"59","author":"SY Jung","year":"2012","unstructured":"Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension (Dallas, Tex: 1979). 2012;59(2):205\u201311.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"3","key":"4437_CR78","doi-asserted-by":"publisher","first-page":"e6929","DOI":"10.1002\/cam4.6929","volume":"13","author":"AL Sutton","year":"2024","unstructured":"Sutton AL, He J, Bottinor W, Hong S, Mitchell K, Hines AL. Examining hypertension risk among black and white breast cancer survivors. Cancer Med. 2024;13(3):e6929.","journal-title":"Cancer Med"},{"issue":"10","key":"4437_CR79","first-page":"1615","volume":"21","author":"JA Largent","year":"2010","unstructured":"Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, et al. Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort. Cancer Causes Control. 2010;21(10):1615\u201324.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"4437_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31083\/j.fbl2906223","volume":"29","author":"H Naderi-Meshkin","year":"2024","unstructured":"Naderi-Meshkin H, Setyaningsih WAW. Endothelial cell dysfunction: onset progression consequences. Front Biosci (Landmark Ed). 2024;29(6):223.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"4437_CR81","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/jcdd9050136","volume":"9","author":"P Ambrosino","year":"2022","unstructured":"Ambrosino P, Bachetti T, D\u2019Anna SE, Galloway B, Bianco A, D\u2019Agnano V et al. Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension. J Cardiovasc Dev Disease. 2022;9(5):136.","journal-title":"J Cardiovasc Dev disease"},{"key":"4437_CR82","doi-asserted-by":"publisher","first-page":"798958","DOI":"10.3389\/fmed.2021.798958","volume":"8","author":"G Gallo","year":"2021","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med. 2021;8:798958.","journal-title":"Front Med"},{"issue":"8","key":"4437_CR83","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1002\/mco2.651","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang X, He B. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm. 2024;5(8):e651.","journal-title":"MedComm"},{"issue":"1","key":"4437_CR84","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-025-02346-0","volume":"10","author":"MJ Herzog","year":"2025","unstructured":"Herzog MJ, M\u00fcller P, Lechner K, Stiebler M, Arndt P, Kunz M, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10(1):282.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4437_CR85","first-page":"103","volume":"34","author":"C Lao","year":"2023","unstructured":"Lao C, Gurney J, Stanley J, Krebs J, Meredith I, Campbell I, et al. Association of diabetes and breast cancer characteristics at diagnosis. Cancer Causes Control. 2023;34(2):103\u201311.","journal-title":"Cancer Causes Control"},{"key":"4437_CR86","doi-asserted-by":"publisher","first-page":"829798","DOI":"10.3389\/fonc.2022.829798","volume":"12","author":"N Wei","year":"2022","unstructured":"Wei N, Lu J, Lin Z, Wang X, Cai M, Jiang S, et al. Systemic evaluation of the effect of diabetes mellitus on breast cancer in a mouse model. Front Oncol. 2022;12:829798.","journal-title":"Front Oncol"},{"issue":"11","key":"4437_CR87","doi-asserted-by":"publisher","first-page":"e0276913","DOI":"10.1371\/journal.pone.0276913","volume":"17","author":"J Gurney","year":"2022","unstructured":"Gurney J, Stanley J, Teng A, Krebs J, Koea J, Lao C, et al. Cancer and diabetes co-occurrence: a national study with 44 million person-years of follow-up. PLoS ONE. 2022;17(11):e0276913.","journal-title":"PLoS ONE"},{"issue":"1","key":"4437_CR88","first-page":"e21712","volume":"14","author":"M Srinivasan","year":"2022","unstructured":"Srinivasan M, Arzoun H, Gk LB, Thangaraj SR. A systematic review: does insulin resistance affect the risk and survival outcome of breast cancer in women? Cureus. 2022;14(1):e21712.","journal-title":"Cureus"},{"key":"4437_CR89","doi-asserted-by":"publisher","first-page":"101710","DOI":"10.1016\/j.canep.2020.101710","volume":"66","author":"WR Lawrence","year":"2020","unstructured":"Lawrence WR, Hosler AS, Gates Kuliszewski M, Leinung MC, Zhang X, Schymura MJ, et al. Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among medicaid-insured women diagnosed with breast cancer. Cancer Epidemiol. 2020;66:101710.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"4437_CR90","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/cancers16020299","volume":"16","author":"W Garczorz","year":"2024","unstructured":"Garczorz W, Kosowska A, Francuz T. Antidiabetic drugs in breast cancer patients. Cancers. 2024;16(2:299).","journal-title":"Cancers"},{"issue":"3","key":"4437_CR91","first-page":"e2040","volume":"7","author":"R Lawrenson","year":"2024","unstructured":"Lawrenson R, Lao C, Stanley J, Teng A, Kuper-Hommel M, Campbell I et al. Does diabetes affect breast cancer survival? Cancer reports (Hoboken, NJ). 2024;7(3):e2040.","journal-title":"Cancer Rep (Hoboken, NJ)"},{"issue":"4","key":"4437_CR92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41416-023-02345-4","volume":"129","author":"F Xiong","year":"2023","unstructured":"Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, et al. Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. Br J Cancer. 2023;129(4):648\u201355.","journal-title":"Br J Cancer"},{"issue":"3","key":"4437_CR93","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.annonc.2020.12.008","volume":"32","author":"YM Park","year":"2021","unstructured":"Park YM, Bookwalter DB, O\u2019Brien KM, Jackson CL, Weinberg CR, Sandler DP. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer. Annals Oncol : Official J Eur Soc Med Oncol. 2021;32(3):351\u20139.","journal-title":"Annals Oncol : Official J Eur Soc Med Oncol"},{"issue":"5","key":"4437_CR94","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1159\/000524513","volume":"17","author":"A Tobe","year":"2022","unstructured":"Tobe A, Horimoto Y, Kobayashi K, Kamisada N, Hirano M. Impact of diabetes on patient outcomes in breast cancer patients. Breast Care (Basel Switzerland). 2022;17(5):480\u20135.","journal-title":"Breast Care (Basel Switzerland)"},{"issue":"1","key":"4437_CR95","doi-asserted-by":"publisher","first-page":"113862","DOI":"10.1016\/j.yexcr.2023.113862","volume":"434","author":"M Monteiro","year":"2024","unstructured":"Monteiro M, Zhang X, Yee D. Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells. Exp Cell Res. 2024;434(1):113862.","journal-title":"Exp Cell Res"},{"key":"4437_CR96","doi-asserted-by":"publisher","first-page":"732027","DOI":"10.1155\/2012\/732027","volume":"2012","author":"C Villarreal-Garza","year":"2012","unstructured":"Villarreal-Garza C, Shaw-Dulin R, Lara-Medina F, Bacon L, Rivera D, Urzua L, et al. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Experimental Diabetes Res. 2012;2012:732027.","journal-title":"Experimental Diabetes Res"},{"issue":"3","key":"4437_CR97","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/ph17030396","volume":"17","author":"KA Corleto","year":"2024","unstructured":"Corleto KA, Strandmo JL, Giles ED. Metformin and breast cancer: current findings and future perspectives from preclinical and clinical studies. Pharmaceuticals (Basel Switzerland). 2024;17(3):396.","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"issue":"1","key":"4437_CR98","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biomedicines9010003","volume":"9","author":"T Salvatore","year":"2020","unstructured":"Salvatore T, Pafundi PC, Galiero R, Rinaldi L, Caturano A, Vetrano E et al. Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? Biomedicines. 2020;9(1):3.","journal-title":"Biomedicines"},{"key":"4437_CR99","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.2147\/IJGM.S421558","volume":"16","author":"A Rachman","year":"2023","unstructured":"Rachman A, Fiantoro ZH, Sutandyo N, Priantono D, Romadhon PZ, Jonlean R. Metabolic profile and negatively association between insulin resistance and metastatic incidence in Indonesian primary invasive breast cancer: a cross-sectional study. Int J Gen Med. 2023;16:3257\u201365.","journal-title":"Int J Gen Med"},{"issue":"2","key":"4437_CR100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gendis.2019.09.006","volume":"8","author":"SS Mohanty","year":"2021","unstructured":"Mohanty SS, Mohanty PK. Obesity as potential breast cancer risk factor for postmenopausal women. Genes Dis. 2021;8(2):117\u201323.","journal-title":"Genes Dis"},{"issue":"11","key":"4437_CR101","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/ijms22115421","volume":"22","author":"S Hibino","year":"2021","unstructured":"Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M et al. Inflammation-Induced tumorigenesis and metastasis. Int J Mol Sci. 2021;22(11):5421.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4437_CR102","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13058-018-1029-4","volume":"20","author":"M Bousquenaud","year":"2018","unstructured":"Bousquenaud M, Fico F, Solinas G, R\u00fcegg C, Santamaria-Mart\u00ednez A. Obesity promotes the expansion of metastasis-initiating cells in breast cancer. Breast Cancer Res. 2018;20(1):104.","journal-title":"Breast Cancer Res"},{"key":"4437_CR103","volume-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Volume 361. New York, NY: Science; 2018. 6409."},{"issue":"7","key":"4437_CR104","first-page":"488","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation. Progression Metastasis. 2025;14(7):488.","journal-title":"Progression Metastasis"},{"key":"4437_CR105","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"8","author":"N Clere","year":"2020","unstructured":"Clere N, Renault S, Corre I. Endothelial-to-Mesenchymal transition in cancer. Front Cell Dev Biology. 2020;8:747.","journal-title":"Front Cell Dev Biology"},{"key":"4437_CR106","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fimmu.2018.00294","volume":"9","author":"JG Cho","year":"2018","unstructured":"Cho JG, Lee A, Chang W, Lee MS, Kim J. Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 2018;9:294.","journal-title":"Front Immunol"},{"key":"4437_CR107","doi-asserted-by":"publisher","first-page":"668731","DOI":"10.3389\/fonc.2021.668731","volume":"11","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Gaggar S, G\u00f6genur I. Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy. Front Oncol. 2021;11:668731.","journal-title":"Front Oncol"},{"issue":"1","key":"4437_CR108","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12905-023-02543-5","volume":"23","author":"T Dehesh","year":"2023","unstructured":"Dehesh T, Fadaghi S, Seyedi M, Abolhadi E, Ilaghi M, Shams P, et al. The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):392.","journal-title":"BMC Womens Health"},{"issue":"4","key":"4437_CR109","doi-asserted-by":"publisher","first-page":"337","DOI":"10.32768\/abc.2024114337-344","volume":"11","author":"M Mirzaeva","year":"2024","unstructured":"Mirzaeva M, Iriskulov B, Alimkhodjaeva L. Potential of serum IL-6 as a predictor of tum\u043er hist\u043el\u043egi\u0441\u0430l m\u0430nif\u0435st\u0430ti\u043ens in pr\u0435m\u0435n\u043e\u0440\u0430us\u0430l br\u0435\u0430st c\u0430n\u0441\u0435r with m\u0435t\u0430b\u043eli\u0441 s\u0443ndr\u043em\u0435: IL6 as a tumor predictor. Arch Breast Cancer. 2024;11(4):337\u201344.","journal-title":"Arch Breast Cancer"},{"issue":"1","key":"4437_CR110","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-022-06664-7","volume":"196","author":"M Klintman","year":"2022","unstructured":"Klintman M, Rosendahl AH, Randeris B, Eriksson M, Czene K, Hall P, et al. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Res Treat. 2022;196(1):185\u201396.","journal-title":"Breast Cancer Res Treat"},{"key":"4437_CR111","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejogrb.2018.03.050","volume":"230","author":"D Laudisio","year":"2018","unstructured":"Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Obesity and breast cancer in premenopausal women: current evidence and future perspectives. Eur J Obstet Gynecol Reproduct Biol. 2018;230:217\u201321.","journal-title":"Eur J Obstet Gynecol Reproduct Biol"},{"issue":"10","key":"4437_CR112","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DSM Chan","year":"2014","unstructured":"Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Annals Oncol. 2014;25(10):1901\u201314.","journal-title":"Annals Oncol"},{"key":"4437_CR113","doi-asserted-by":"publisher","DOI":"10.32768\/abc.8063149720-581","author":"M Mirzaeva","year":"2025","unstructured":"Mirzaeva M, Iriskulov B, Asrorov A, Hudoynazarov I, Norbekova M, Tadjibayeva R et al. Association of obesity with premenopausal breast cancer: analyses on molecular subtypes: metabolic markers in BC. Arch Breast Cancer. 2025. https:\/\/doi.org\/10.32768\/abc.8063149720-581","journal-title":"Arch Breast Cancer"},{"key":"4437_CR114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.breast.2020.11.014","volume":"55","author":"K Saleh","year":"2021","unstructured":"Saleh K, Carton M, Dieras V, Heudel PE, Brain E, D\u2019Hondt V, et al. Impact of body mass index on overall survival in patients with metastatic breast cancer. Breast (Edinburgh Scotland). 2021;55:16\u201324.","journal-title":"Breast (Edinburgh Scotland)"},{"issue":"10","key":"4437_CR115","first-page":"1944","volume":"31","author":"LT Olsson","year":"2022","unstructured":"Olsson LT, Walens A, Hamilton AM, Benefield HC, Fleming JM, Carey LA, et al. Obesity and breast cancer metastasis across genomic Subtypes. cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research. Cosponsored Am Soc Prev Oncol. 2022;31(10):1944\u201351.","journal-title":"Cosponsored Am Soc Prev Oncol"},{"issue":"3","key":"4437_CR116","doi-asserted-by":"publisher","first-page":"e213520","DOI":"10.1001\/jamanetworkopen.2021.3520","volume":"4","author":"F Petrelli","year":"2021","unstructured":"Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and Meta-analysis. JAMA Netw Open. 2021;4(3):e213520.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4437_CR117","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41523-023-00603-5","volume":"9","author":"LS Puklin","year":"2023","unstructured":"Puklin LS, Li F, Cartmel B, Zhao J, Sanft T, Lisevick A, et al. Post-diagnosis weight trajectories and mortality among women with breast cancer. Npj Breast Cancer. 2023;9(1):98.","journal-title":"Npj Breast Cancer"},{"issue":"1","key":"4437_CR118","doi-asserted-by":"publisher","first-page":"11378","DOI":"10.1038\/s41598-018-28806-y","volume":"8","author":"X Zhao","year":"2018","unstructured":"Zhao X, Xu Z, Li H. Author correction: NSAIDs use and reduced metastasis in cancer patients: results from a meta-analysis. Sci Rep. 2018;8(1):11378.","journal-title":"Sci Rep"},{"key":"4437_CR119","first-page":"3418975","volume":"2019","author":"RSY Wong","year":"2019","unstructured":"Wong RSY. Role of nonsteroidal anti-inflammatory drugs (NSAIDs) in cancer prevention and cancer promotion. Adv Pharmacol Sci. 2019;2019:3418975.","journal-title":"Adv Pharmacol Sci"},{"issue":"3","key":"4437_CR120","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/ijms23031432","volume":"23","author":"OR Kolawole","year":"2022","unstructured":"Kolawole OR, Kashfi K. NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase. Int J Mol Sci. 2022;23(3):1432.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4437_CR121","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1607-551X(08)70162-1","volume":"24","author":"WC Hung","year":"2008","unstructured":"Hung WC. Anti-metastatic action of non-steroidal anti-inflammatory drugs. Kaohsiung J Med Sci. 2008;24(8):392\u20137.","journal-title":"Kaohsiung J Med Sci"},{"key":"4437_CR122","doi-asserted-by":"publisher","first-page":"1579876","DOI":"10.3389\/fonc.2025.1579876","volume":"15","author":"L Garc\u00eda-Est\u00e9vez","year":"2025","unstructured":"Garc\u00eda-Est\u00e9vez L, Gonz\u00e1lez-Rodr\u00edguez M, Calvo I, Orta A, Gi\u00f3n M, Moreno-Bueno G, et al. Obesity, overweight and breast cancer: new clinical data and implications for practice. Front Oncol. 2025;15:1579876.","journal-title":"Front Oncol"},{"issue":"1","key":"4437_CR123","doi-asserted-by":"publisher","first-page":"21145","DOI":"10.1038\/s41598-022-25043-2","volume":"12","author":"F Acevedo","year":"2022","unstructured":"Acevedo F, Walbaum B, Mu\u00f1iz S, Petric M, Mart\u00ednez R, Guerra C, et al. Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy. Sci Rep. 2022;12(1):21145.","journal-title":"Sci Rep"},{"issue":"6","key":"4437_CR124","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaccao.2024.07.020","volume":"6","author":"T Caller","year":"2024","unstructured":"Caller T, Fardman A, Gerber Y, Moshkovits Y, Tiosano S, Kaplan A, et al. Atherosclerotic cardiovascular diseases are associated with incident metastatic and nonmetastatic cancer. JACC CardioOncol. 2024;6(6):949\u201361.","journal-title":"JACC CardioOncol"},{"key":"4437_CR125","doi-asserted-by":"publisher","first-page":"1112047","DOI":"10.3389\/fcvm.2023.1112047","volume":"10","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Xing A, Hidru TH, Li J, Yang X, Chen S, et al. The association between arterial stiffness and cancer occurrence: data from Kailuan cohort study. Front Cardiovasc Med. 2023;10:1112047.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"4437_CR126","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/biology12070896","volume":"12","author":"A Scalia","year":"2023","unstructured":"Scalia A, Doumani L, Kindt N, Journ\u00e9 F, Trelcat A, Carlier S. The interplay between atherosclerosis and cancer: breast cancer cells increase the expression of endothelial cell adhesion markers. Biology. 2023;12(7):896.","journal-title":"Biology"},{"issue":"2","key":"4437_CR127","doi-asserted-by":"publisher","first-page":"e71-e9.e4","DOI":"10.1016\/j.clbc.2023.10.007","volume":"24","author":"JW Melson","year":"2024","unstructured":"Melson JW, Koethe B, Mohanty S, Babroudi S, Bao C, Chunduru A, et al. Atherosclerotic cardiovascular disease risk and longitudinal risk factor management among patients with breast cancer. Clin Breast Cancer. 2024;24(2):e71-e9.e4.","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"4437_CR128","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11547-023-01611-y","volume":"128","author":"SC Lee","year":"2023","unstructured":"Lee SC, Pirikahu S, Fritschi L, Boyle T, Schultz C, Wylie E, et al. The association between breast arterial calcification and atherosclerotic cardiovascular disease in an Australian population-based breast cancer case-control study. Radiol Med. 2023;128(4):426\u201333.","journal-title":"Radiol Med"},{"issue":"1","key":"4437_CR129","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41420-025-02428-6","volume":"11","author":"Y Luo","year":"2025","unstructured":"Luo Y, Liu J, Qu P, Han S, Li X, Wang Y, et al. The crosstalk of breast cancer and ischemic heart disease. Cell Death Discov. 2025;11(1):185.","journal-title":"Cell Death Discov"},{"issue":"2","key":"4437_CR130","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jcct.2021.09.009","volume":"16","author":"A Pope","year":"2022","unstructured":"Pope A, Thomson L, Cantu S, Setia G, Torosyan N, Merz NB, et al. Detection of subclinical atherosclerosis from PET-CT in patients with breast cancer. J Cardiovasc Comput Tomogr. 2022;16(2):189\u201390.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"4437_CR131","doi-asserted-by":"publisher","first-page":"e2452890","DOI":"10.1001\/jamanetworkopen.2024.52890","volume":"8","author":"I Angelov","year":"2025","unstructured":"Angelov I, Haas AM, Brock E, Luo L, Zhao J, Smith BD, et al. Cardiovascular disease and breast cancer stage at diagnosis. JAMA Netw Open. 2025;8(1):e2452890.","journal-title":"JAMA Netw Open"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04437-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:46:58Z","timestamp":1781632018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4437"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04437-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}